DARE
Dare Bioscience Inc
NASDAQ: DARE · HEALTHCARE · BIOTECHNOLOGY
$2.28
+8.57% today
Updated 2026-04-30
Market cap
$30.72M
P/E ratio
—
P/S ratio
29.82x
EPS (TTM)
$-1.20
Dividend yield
—
52W range
$1 – $3
Volume
0.4M
Dare Bioscience Inc (DARE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $305000.00 | $625000.00 | $6000.00 | $80000.00 | $0.00 | $766000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.00M | $10.00M | $2.81M | $9784.00 | $1.03M |
| Revenue growth (YoY) | — | +104.9% | -99.0% | +1233.3% | -100.0% | — | -100.0% | — | — | — | — | +0.0% | -71.9% | -99.7% | +10429.4% |
| Cost of revenue | $363000.00 | — | — | $0.00 | $192000.00 | $400000.00 | $0.00 | $625000.00 | $11137.00 | $83333.00 | $100000.00 | $47617.00 | $21.64M | $14.31M | $2.45M |
| Gross profit | $-58000.00 | $625000.00 | $6000.00 | $80000.00 | $-192000.00 | $366000.00 | $0.00 | $-2440.00 | $-11137.00 | $-83333.00 | $-100000.00 | $10.00M | $-18.83M | $-14.30M | $-1.42M |
| Gross margin | -19.0% | 100.0% | 100.0% | 100.0% | — | 47.8% | — | — | — | — | -1.0% | 100.0% | -670.6% | -146110.2% | -137.5% |
| R&D | $13.48M | $15.81M | $9.70M | $11.77M | $25.95M | $27.57M | $984749.00 | $6.41M | $8.55M | $20.77M | $30.62M | $30.04M | $21.54M | $14.21M | $5.52B |
| SG&A | — | $6.39M | $6.17M | $8.59M | $11.22M | $10.36M | $2.71M | $5.28M | $5.80M | $6.11M | $7.79M | $11.24M | $11.31M | $8.36M | $8.76M |
| Operating income | $-18.88M | $-21.57M | $-15.86M | $-20.28M | $-37.17M | $-37.15M | $-11.18M | $-16.88M | $-14.34M | $-27.40M | $-39.07M | $-31.39M | $-30.94M | $-23.45M | $-13.55M |
| Operating margin | -6189.5% | -3452.0% | -264333.3% | -25348.8% | — | -4850.4% | — | — | — | — | -390.7% | -313.9% | -1101.9% | -239692.2% | -1315.5% |
| EBITDA | $-18.55M | $-21.19M | $-15.46M | $-22.13M | $-36.97M | $-36.81M | $-11.18M | $-11.69M | $-14.25M | $-27.36M | $-39.04M | $-31.36M | $-30.70M | $-23.41M | $-11.40M |
| EBITDA margin | -6083.0% | -3390.1% | -257650.0% | -27666.3% | — | -4805.1% | — | — | — | — | -390.4% | -313.6% | -1093.4% | -239259.6% | -1106.7% |
| EBIT | $-18.92M | $-21.53M | $-15.66M | $-22.26M | $-37.16M | $-37.07M | $-13.91M | $-11.69M | $-14.26M | $-27.40M | $-39.07M | $-31.39M | $-30.74M | $-23.45M | $-13.55M |
| Interest expense | $26000.00 | $567000.00 | $1.49M | $1.08M | $2.43M | $2.24M | $322629.00 | $0.00 | $0.00 | $0.00 | $372407.00 | $437.75M | — | — | $822709.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-19.56M | $-22.10M | $-17.14M | $-23.34M | $-39.59M | $-39.30M | $-11.50M | $-16.74M | $-14.26M | $-27.40M | $-38.70M | $406.80M | $-30.16M | $-4.05M | $-13.40M |
| Net income growth (YoY) | — | -13.0% | +22.4% | -36.2% | -69.6% | +0.7% | +70.7% | -45.5% | +14.8% | -92.1% | -41.2% | +1151.3% | -107.4% | +86.6% | -230.6% |
| Profit margin | -6414.1% | -3536.2% | -285716.7% | -29177.5% | — | -5131.2% | — | — | — | — | -387.0% | 4068.0% | -1074.2% | -41430.9% | -1300.7% |